Shevon L. Scarafile

Partner

A member of the firm’s White Collar Criminal Defense Group, Shevon L. Scarafile represents pharmaceutical companies, medical device manufacturers, and multinational companies facing government investigations arising under the False Claims Act, the Medicare Anti-Kickback Statute, the Federal Food, Drug, and Cosmetic (FD&C) Act, the Foreign Corrupt Practices Act (FCPA), and other US federal and state civil and criminal fraud statutes. She also conducts multiyear government and corporate internal investigations.

Extended Profile

Shevon also represents plaintiffs and defendants in complex commercial litigation and class actions in both US federal and state courts. She also has litigated against foreign defendants.

Her active pro bono work includes representing prisoners in civil rights actions, criminal defendants in state and federal courts, and indigent clients in civil disputes.

selected representations

Attained declination of government intervention and dismissal by relators in case alleging violations of False Claims Act against information technology company.
Defended a major chemical manufacturer in responding to an investigation regarding allegations of violations of the Controlled Substances Act and Drug Enforcement Administration regulations
Conducted an internal investigation for a national health insurance company and assessed whistleblower allegations under the False Claims Act
Represented pharmaceutical manufacturer in investigation regarding allegations of violations of the False Claims Act, Poison Prevention Packaging Act, and the Consumer Product Safety Improvement Act
Defended a medical device manufacturer in responding to investigations conducted by the Department of Justice regarding allegations of violations of the Federal Food, Drug and Cosmetic Act
Defended a medical device manufacturer in responding to investigations regarding allegations of Foreign Corrupt Practices Act violations.
Conducted an internal investigation and advised a pharmaceutical manufacturer regarding concerns with off-label sales and marketing
Represented hospital in responding to inquiries received from Securities Exchange Commission.
Represented a medical device manufacturer as plaintiff in breach of contract action against foreign defendant.
Represented a Fortune 50 company as plaintiff in litigation regarding violations of the Lanham Act and several state false advertising laws
Defended a major restructuring company in litigation regarding allegations of mismanagement of bankruptcy